The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity
Open accessAbstract
Nrf2 and NF-κB are important regulators of the response to oxidative stress and inflammation in the body. Previous pharmacological and genetic studies have confirmed crosstalk between the two. The deficiency of Nrf2 elevates the expression of NF-κB, leading to increased production of inflammatory factors, while NF-κB can affect the expression of downstream target genes by regulating the transcription and activity of Nrf2. At the same time, many therapeutic drug-induced organ toxicities, including hepatotoxicity, nephrotoxicity, cardiotoxicity, pulmonary toxicity, dermal toxicity, and neurotoxicity, have received increasing attention from researchers in clinical practice. Drug-induced organ injury can destroy body function, reduce the patients’ quality of life, and even threaten the lives of patients. Therefore, it is urgent to find protective drugs to ameliorate drug-induced injury. There is substantial evidence that protective medications can alleviate drug-induced organ toxicity by modulating both Nrf2 and NF-κB signaling pathways. Thus, it has become increasingly important to explore the crosstalk mechanism between Nrf2 and NF-κB in drug-induced toxicity. In this review, we summarize the potential molecular mechanisms of Nrf2 and NF-κB pathways and the important effects on adverse effects including toxic reactions and look forward to finding protective drugs that can target the crosstalk between the two.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Transcriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,192
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Hospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., Reisch, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,926
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831
Nrf2 signaling pathway: pivotal roles in inflammation
Ahmed, S. M. U., Luo, L., Namani, A., Wang, X. J., & Tang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.005 · Cited by 1,794
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,414
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.-C., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,359
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Non-canonical NF-κB signaling pathway
Sun, S.-C. (2011) · Cell Research · doi:10.1038/cr.2010.177 · Cited by 1,197
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Vanherweghem, J.-L., Tielemans, C., Abramowicz, D., Depierreux, M., Vanhaelen-Fastre, R., Vanhaelen, M., Dratwa, M., Richard, C., Vandervelde, D., Verbeelen, D., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92984-2 · Cited by 1,076
Jaul, E., & Barron, J. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00335 · Cited by 946
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
NF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
Wang, Y., Xu, C.-F., Liu, Y.-J., Mao, Y.-F., Lv, Z., Li, S.-Y., Zhu, X.-Y., & Jiang, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477112 · Cited by 825
Self-citationAn important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen
Chan, K., Han, X.-D., & Kan, Y. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081082098 · Cited by 770
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Rada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01204-10 · Cited by 759 · cited 1×
“GSK-3 is responsible for phosphorylating a domain of Nrf2 (aspartate, serine, glycine, isoleucine, serine; DSGIS), creating a recognition motif for β-TrCP and then presenting Nrf2 to the Skp1-Cul1-Rbx1/Roc1 complex, finally leading to an alternative pathway for inhibition of Nrf2 (Rada et al., 2011; Cuadrado, 2015) (F…”
BackgroundActivation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738
Enomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728
The noncanonical NF‐κB pathway
Sun, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01088.x · Cited by 722
Liu, G.-H., Qu, J., & Shen, X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.002 · Cited by 697 · cited 3×
“, histone deacetylases (HDACs)) (Liu et al., 2008) (Figure 2B).”
BackgroundToward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2013) · Oncogene · doi:10.1038/onc.2012.388 · Cited by 657
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
Transcriptional regulation via the NF-κB signaling module
Hoffmann, A., Natoli, G., & Ghosh, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209933 · Cited by 629
Structural basis of Keap1 interactions with Nrf2
Canning, P., Sorrell, F. J., & Bullock, A. N. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.034 · Cited by 592
Brambilla, R., Bracchi-Ricard, V., Hu, W.-H., Frydel, B., Bramwell, A., Karmally, S., Green, E. J., & Bethea, J. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041918 · Cited by 586
Clearing the brain's amyloid cobwebs
Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Drug-induced mitochondrial dysfunction and cardiotoxicity
Varga, Z. V., Ferdinandy, P., Liaudet, L., & Pacher, P. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2015 · Cited by 531
Modulating NRF2 in Disease: Timing Is Everything
Dodson, M., de la Vega, M. R., Cholanians, A. B., Schmidlin, C. J., Chapman, E., & Zhang, D. D. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021856 · Cited by 522
Nrf2: friend or foe for chemoprevention?
Kensler, T. W., & Wakabayashi, N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp231 · Cited by 484
Rada, P., Rojo, A. I., Evrard-Todeschi, N., Innamorato, N. G., Cotte, A., Jaworski, T., Tobón-Velasco, J. C., Devijver, H., García-Mayoral, M. F., Van Leuven, F., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00180-12 · Cited by 474
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473 · cited 5×
“Nrf2 signaling pathway is an important way to regulate cellular oxidative stress, which plays an important role in DILI (Tong et al., 2006).”
BackgroundInfluentialAcute kidney injury in China: a cross-sectional survey
Yang, L., Xing, G., Wang, L., Wu, Y., Li, S., Xu, G., He, Q., Chen, J., Chen, M., Liu, X., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00344-x · Cited by 469
Self-citationEschenhagen, T., Force, T., Ewer, M. S., de Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J.-L., Brutsaert, D. L., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq213 · Cited by 413
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
Lee, D.-F., Kuo, H.-P., Liu, M., Chou, C.-K., Xia, W., Du, Y., Shen, J., Chen, C.-T., Huo, L., Hsu, M.-C., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.025 · Cited by 399 · cited 20×
“Toxic reaction Representative drug Representative promising candidate Brief summary of regulatory mechanisms based on Nrf2 and NF-κB References Hepatotoxicity Acetaminophen Salvianolic acid B/C • Regulating drug-metabolizing enzymes, transporter and antioxidant genes through the Nrf2/ARE pathway Wang et al. (2019a), L…”
BackgroundInfluentialNRF2-regulation in brain health and disease: Implication of cerebral inflammation
Sandberg, M., Patil, J., D'Angelo, B., Weber, S. G., & Mallard, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.004 · Cited by 390
Triptolide: Progress on research in pharmacodynamics and toxicology
Li, X.-J., Jiang, Z.-Z., & Zhang, L.-Y. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.06.006 · Cited by 378
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Ghoreschi, K., Brück, J., Kellerer, C., Deng, C., Peng, H., Rothfuss, O., Hussain, R. Z., Gocke, A. R., Respa, A., Glocova, I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100977 · Cited by 352
Zhao, L., Qi, Y., Xu, L., Tao, X., Han, X., Yin, L., & Peng, J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.013 · Cited by 344
The role of Nrf2 signaling in counteracting neurodegenerative diseases
Dinkova‐Kostova, A. T., Kostov, R. V., & Kazantsev, A. G. (2018) · The FEBS Journal · doi:10.1111/febs.14379 · Cited by 342
Cuadrado, A., Martín-Moldes, Z., Ye, J., & Lastres-Becker, I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540633 · Cited by 320
New insights into NF-κB regulation and function
Sun, S.-C., & Ley, S. C. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.003 · Cited by 318
Noncanonical NF-κB Signaling in Health and Disease
Cildir, G., Low, K. C., & Tergaonkar, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.002 · Cited by 301
Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury
Saeedi, B. J., Liu, K. H., Owens, J. A., Hunter-Chang, S., Camacho, M. C., Eboka, R. U., Chandrasekharan, B., Baker, N. F., Darby, T. M., Robinson, B. S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.006 · Cited by 295
Molecular mechanism of TNF signaling and beyond
LIU, Z.-G. (2005) · Cell Research · doi:10.1038/sj.cr.7290259 · Cited by 280
Toxicity of triptolide and the molecular mechanisms involved
Xi, C., Peng, S., Wu, Z., Zhou, Q., & Zhou, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.003 · Cited by 279
A role for superoxide in gentamicin-mediated nephropathy in rats
Cuzzocrea, S., Mazzon, E., Dugo, L., Serraino, I., Di Paola, R., Britti, D., De Sarro, A., Pierpaoli, S., Caputi, A. P., Masini, E., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01749-1 · Cited by 278
Lastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rábano, A., Kirik, D., & Cuadrado, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds143 · Cited by 263
Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP
Cuadrado, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.029 · Cited by 260
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
Peng, C., Ouyang, Y., Lu, N., & Li, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01387 · Cited by 249
Hensley, K. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1414 · Cited by 248
Siggers, T., Chang, A. B., Teixeira, A., Wong, D., Williams, K. J., Ahmed, B., Ragoussis, J., Udalova, I. A., Smale, S. T., & Bulyk, M. L. (2012) · Nature Immunology · doi:10.1038/ni.2151 · Cited by 220
Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression
Bellezza, I., Mierla, A. L., & Minelli, A. (2010) · Cancers · doi:10.3390/cancers2020483 · Cited by 216
Rushworth, S. A., MacEwan, D. J., & O’Connell, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6730 · Cited by 215
Bellezza, I., Tucci, A., Galli, F., Grottelli, S., Mierla, A. L., Pilolli, F., & Minelli, A. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.10.012 · Cited by 215
Lee, T.-S., Tsai, H.-L., & Chau, L.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300498200 · Cited by 211
The clinical and renal consequences of contrast-induced nephropathy
Finn, W. F. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl213 · Cited by 187
Yu, X., Meng, X., Xu, M., Zhang, X., Zhang, Y., Ding, G., Huang, S., Zhang, A., & Jia, Z. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.031 · Cited by 187
Xu, A., Deng, F., Chen, Y., Kong, Y., Pan, L., Liao, Q., Rao, Z., Xie, L., Yao, C., Li, S., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110525 · Cited by 185
Gan, L., Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3049-12.2012 · Cited by 182
Pan, H., Wang, H., Wang, X., Zhu, L., & Mao, L. (2012) · Mediators of Inflammation · doi:10.1155/2012/217580 · Cited by 179
Liu, Y., Lu, F., Kang, L., Wang, Z., & Wang, Y. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0405-7 · Cited by 178
Self-citationKalayarasan, S., Prabhu, P. N., Sriram, N., Manikandan, R., Arumugam, M., & Sudhandiran, G. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.055 · Cited by 176
Zhao, Y.-Y., Wang, H.-L., Cheng, X.-L., Wei, F., Bai, X., Lin, R.-C., & Vaziri, N. D. (2015) · Scientific Reports · doi:10.1038/srep12936 · Cited by 173
Jin, W., Wang, H., Yan, W., Xu, L., Wang, X., Zhao, X., Yang, X., Chen, G., & Ji, Y. (2008) · Mediators of Inflammation · doi:10.1155/2008/725174 · Cited by 172
Kastrati, I., Siklos, M. I., Calderon-Gierszal, E. L., El-Shennawy, L., Georgieva, G., Thayer, E. N., Thatcher, G. R. J., & Frasor, J. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679704 · Cited by 172
The NF-κB Genomic Landscape in Lymphoblastoid B Cells
Zhao, B., Barrera, L. A., Ersing, I., Willox, B., Schmidt, S. C. S., Greenfeld, H., Zhou, H., Mollo, S. B., Shi, T. T., Takasaki, K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.037 · Cited by 171
Hu, L.-Y., Mi, W.-L., Wu, G.-C., Wang, Y.-Q., & Mao-Ying, Q.-L. (2019) · Current Neuropharmacology · doi:10.2174/1570159x15666170915143217 · Cited by 171
Self-citationSong, M.-Y., Kim, E.-K., Moon, W.-S., Park, J.-W., Kim, H.-J., So, H.-S., Park, R., Kwon, K.-B., & Park, B.-H. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.11.007 · Cited by 169
Ji, L.-L., Sheng, Y.-C., Zheng, Z.-Y., Shi, L., & Wang, Z.-T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.035 · Cited by 169
Unveiling the Role of Inflammation and Oxidative Stress on Age-Related Cardiovascular Diseases
de Almeida, A. J. P. O., de Almeida Rezende, M. S., Dantas, S. H., de Lima Silva, S., de Oliveira, J. C. P. L., de Lourdes Assunção Araújo de Azevedo, F., Alves, R. M. F. R., de Menezes, G. M. S., dos Santos, P. F., Gonçalves, T. A. F., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1954398 · Cited by 162
Amyloidosis and Alzheimer’s disease
Ghiso, J., & Frangione, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00149-7 · Cited by 158
Wang, Q., Boliang, W., Xiaoxi, T., Fu, G., Jianbo, X., & Wang, G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109547 · Cited by 156
Breast cancer therapy-associated cardiovascular disease
Zagar, T. M., Cardinale, D. M., & Marks, L. B. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.171 · Cited by 155
SIRT1 Controls Acetaminophen Hepatotoxicity by Modulating Inflammation and Oxidative Stress
Rada, P., Pardo, V., Mobasher, M. A., García‐Martinez, I., Ruíz-Cañas, L., González‐Rodríguez, Á., Sánchez‐Ramos, C., Muntané, J., Alemany, S., James, L. P., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7373 · Cited by 153
Campolo, M., Casili, G., Biundo, F., Crupi, R., Cordaro, M., Cuzzocrea, S., & Esposito, E. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6800 · Cited by 151
Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
Qu, Z., Sun, J., Zhang, W., Yu, J., & Zhuang, C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.028 · Cited by 151
Pan, X., Wu, X., Yan, D., Peng, C. Y., Rao, C., & Yan, H. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.02.002 · Cited by 150
Valcarcel‐Ares, M. N., Gautam, T., Warrington, J. P., Bailey‐Downs, L. C., Sosnowska, D., de Cabo, R., Losonczy, G., Sonntag, W. E., Ungvari, Z. I., & Csiszár, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr229 · Cited by 148
Aladaileh, S. H., Hussein, O. E., Abukhalil, M. H., Saghir, S. A. M., Bin-Jumah, M. N., Alfwuaires, M. A., Germoush, M. O., Almaiman, A. A., & Mahmoud, A. M. (2019) · Antioxidants · doi:10.3390/antiox8100430 · Cited by 147
Jia, Z., Cen, J., Wang, J., Zhang, F., Xia, Q., Wang, X., Chen, X., Wang, R.-C., Hsiao, C., Liu, K., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.04.026 · Cited by 146
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
von Otter, M., Landgren, S., Nilsson, S., Celojevic, D., Bergström, P., Håkansson, A. S., Nissbrandt, H., Droździk, M., Białecka, M. A., Kurzawski, M., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-36 · Cited by 143
Wu, C.-T., Deng, J., Huang, W., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9056845 · Cited by 140
Hassanein, E. H. M., Shalkami, A. S., Khalaf, M. M., Mohamed, W. R., & Hemeida, R. A. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.088 · Cited by 139
Deng, J., Jiang, W., Chen, C., Lee, L., Li, P., Huang, W., Liao, J., Chen, H.-Y., Huang, S., & Huang, G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7912763 · Cited by 138
Kim, S.-W., Lee, H., Shin, J., & Lee, J.-K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.028 · Cited by 133
Yarmohammadi, F., Rezaee, R., & Karimi, G. (2020) · Phytotherapy Research · doi:10.1002/ptr.6882 · Cited by 133
Ju, X., Zhang, H., Zhou, Z., Chen, M., & Wang, Q. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112315 · Cited by 133
Transcriptional Factor NF- κ B as a Target for Therapy in Parkinson's Disease
Flood, P. M., Li, Q., Peterson, L. J., Zhang, F., Shi, J., Gao, H., & Hong, J. (2011) · Parkinson s Disease · doi:10.4061/2011/216298 · Cited by 129
Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation
Song, M., Lee, J., Ryoo, I.-G., Lee, S.-H., Ku, S., & Kwak, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.033 · Cited by 129
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Brück, J., Dringen, R., Amasuno, A., Pau‐Charles, I., & Ghoreschi, K. (2018) · Experimental Dermatology · doi:10.1111/exd.13548 · Cited by 128
Buckley, N. A., Buckley, N. A., Whyte, I. M., O’Connell, D. L., & Dawson, A. H. (1999) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-100102453 · Cited by 127
Zhao, M., Wang, F. S. L., Hu, X., Chen, F., & Chan, H. M. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.007 · Cited by 122
The Transcriptional Specificity of NF-κB Dimers Is Coded within the κB DNA Response Elements
Wang, V. Y., Huang, W. J. M., Asagiri, M., Spann, N. J., Hoffmann, A., Glass, C. K., & Ghosh, G. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.042 · Cited by 121
Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasis
Skibinski, G., Hwang, V., Ando, D. M., Daub, A. C., Lee, A. K., Ravisankar, A., Modan, S., Finucane, M. M., Shaby, B. A., & Finkbeiner, S. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522872114 · Cited by 121
Bradykinin Induces Interleukin‐6 Expression in Astrocytes Through Activation of Nuclear Factor‐κB
Schwaninger, M., Sallmann, S., Petersen, N., Schneider, A., Prinz, S., Libermann, T. A., & Spranger, M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731461.x · Cited by 120
Vacuolar Leukoencephalopathy with Widespread Astrogliosis in Mice Lacking Transcription Factor Nrf2
Hubbs, A. F., Benkovic, S. A., Miller, D. B., O'Callaghan, J. P., Battelli, L. A., Schwegler‐Berry, D., & Ma, Q. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060898 · Cited by 119
Lv, H., Hong, L., Tian, Y., Yin, C., Zhu, C., & Feng, H. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-018-0314-2 · Cited by 119
Lv, H., Zhu, C., Wei, W., Lv, X., Yu, Q., Deng, X., & Ci, X. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153241 · Cited by 116
El-Twab, S. M. A., Hussein, O. E., Hozayen, W. G., Bin-Jumah, M. N., & Mahmoud, A. M. (2019) · Inflammation Research · doi:10.1007/s00011-019-01241-z · Cited by 114
Yardım, A., Kandemır, F. M., Özdemir, S., Küçükler, S., Çomaklı, S., Gür, C., & Çelik, H. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.10.001 · Cited by 113
Yang, R., Song, C., Chen, J., Zhou, L., Jiang, X., Cao, X., Sun, Y., & Zhang, Q. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153211 · Cited by 111
Zhang, Q., Zhao, Y., Talukder, M., Han, Y., Zhang, C., Li, X., & Li, J. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.09.211 · Cited by 110
Yu, J., Xie, J., Mao, X., Wang, M., Li, N., Wang, J., Zhaori, G.-T., & Zhao, R. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.07.055 · Cited by 107
Activation of Nrf2 Protects against Triptolide-Induced Hepatotoxicity
Li, J., Shen, F., Guan, C., Wang, W., Sun, X., Fu, X., Huang, M., Jin, J., & Huang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100685 · Cited by 103
Tang, H., Gao, L., Mao, J., He, H., Liu, J., Cai, X., Lin, H., & Wu, T. (2015) · Cell Stress and Chaperones · doi:10.1007/s12192-015-0654-4 · Cited by 101
Sahu, R., Dua, T. K., Das, S., Feo, V. D., & Dewanjee, S. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.01.034 · Cited by 101
Li, X.-X., Du, F., Liu, H., Ji, J., & Xing, J. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.004 · Cited by 100
Jangra, A., Kwatra, M., Singh, T., Pant, R., Kushwah, P., Ahmed, S., Dwivedi, D. K., Saroha, B., & Lahkar, M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.003 · Cited by 100
Eighteen cases of liver injury following ingestion of Polygonum multiflorum
Dong, H., Slain, D., Cheng, J., Ma, W., & Liang, W. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2013.12.008 · Cited by 98
Mahmoud, A. M., Germoush, M. O., Al‐Anazi, K. M., Mahmoud, A. H., Farah, M. A., & Allam, A. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.171 · Cited by 98
Ansari, M. A., Raish, M., Ahmad, A., Ahmad, S. F., Shahid, M., Kazi, M., Shakeel, F., Korashy, H. M., & Bakheet, S. A. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.09.014 · Cited by 97
von Otter, M., Landgren, S., Nilsson, S., Zetterberg, M., Celojevic, D., Bergström, P., Minthon, L., Bogdanović, N., Andreasen, N., Gustafson, D., et al. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.12.007 · Cited by 96
Systems biology approaches to adverse drug effects: the example of cardio-oncology
Brown, S.-A. N., Sandhu, N. P., & Herrmann, J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.168 · Cited by 94
A novel effect of Aprepitant: Protection for cisplatin-induced nephrotoxicity and hepatotoxicity
Ün, H., Uğan, R. A., Köse, D., Bayır, Y., Çadırcı, E., Selli, J., & Halıcı, Z. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173168 · Cited by 92
An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment
Keleku-Lukwete, N., Suzuki, M., & Yamamoto, M. P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7358 · Cited by 91
Wang, X. J., Li, Y., Luo, L., Wang, H., Chi, Z., Xin, A., Li, X., Wu, J., & Tang, X. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.010 · Cited by 87
Gong, D.-J., Wang, L., Yang, Y., Zhang, J., & Liu, X. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1643737 · Cited by 86
Self-citationErythropoietin protects sensory axons against paclitaxel-induced distal degeneration
Melli, G., Jack, C., Lambrinos, G. L., Ringkamp, M., & Höke, A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.014 · Cited by 84
Lv, H., Xiao, Q., Zhou, J., Feng, H., Liu, G., & Ci, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00147 · Cited by 83
Yardım, A., Kandemır, F. M., Çomaklı, S., Özdemir, S., Çağlayan, C., Küçükler, S., & Çelik, H. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03174-0 · Cited by 83
Ma, W., Li, M., Ma, H., Li, W., Liu, L., Yin, Y., Zhou, X., & Hou, G. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117139 · Cited by 82
Wei, C.-B., Tao, K., Jiang, R., Zhou, L., Zhang, Q., & Yuan, C. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.026 · Cited by 81
Melatonin attenuates gentamicin-induced nephrotoxicity and oxidative stress in rats
Lee, I.-C., Kim, S., Lee, S., Baek, H., Moon, C., Kim, S., Park, S., Kim, H.-C., & Kim, J.-C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0849-8 · Cited by 79
Gerdes, S., Shakery, K., & Mrowietz, U. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07779.x · Cited by 77
Wu, J., Liu, X., Fan, J., Chen, W., Wang, J., Zeng, Y., Feng, X., Yu, X., & Yang, X. (2014) · Toxicology · doi:10.1016/j.tox.2014.01.008 · Cited by 77
Hassanein, E. H. M., Mohamed, W. R., Shalkami, A. S., Khalaf, M. M., & Hemeida, R. A. M. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.03.041 · Cited by 76
Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein
Li, G., Chen, J., Zhang, H., Cao, X.-Y., Sun, C., Peng, F., Yin, Y.-P., Lin, Z., Yu, L., Chen, Y., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/4582412 · Cited by 76
Multiple mechanisms of dimethyl fumarate in amyloid β‐induced neurotoxicity in human neuronal cells
Campolo, M., Casili, G., Lanza, M., Filippone, A., Paterniti, I., Cuzzocrea, S., & Esposito, E. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13358 · Cited by 74
Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-κB and Nrf2 signalling
Minelli, A., Grottelli, S., Mierla, A. L., Pinnen, F., Cacciatore, I., & Bellezza, I. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.12.006 · Cited by 73
Zhou, Z., Kandhare, A. D., Kandhare, A. A., & Bodhankar, S. L. (2019) · EXCLI journal · doi:10.17179/excli2019-1094 · Cited by 73
Fayi, M. S. A., Otifi, H. M., Alshyarba, M., Dera, A. A., & Rajagopalan, P. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1722136 · Cited by 73
Wang, Z., Hao, W.-N., Hu, J., Mi, X.-J., Han, Y., Ren, S., Jiang, S., Wang, Y., Li, X., & Li, W. (2019) · Antioxidants · doi:10.3390/antiox8090395 · Cited by 71
Self-citationA special issue on NF-κB signaling and function
Sun, S., & Liu, Z. G. (2011) · Cell Research · doi:10.1038/cr.2011.1 · Cited by 70
Meng, Y.-K., Li, C., Li, R., He, L.-Z., Cui, H., Yin, P., Zhang, C.-E., Li, P.-Y., Sang, X., Wang, Y., et al. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.32 · Cited by 70
Self-citationSangaraju, R., Alavala, S., Nalban, N., Jerald, M. K., & Sistla, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107754 · Cited by 67
Herpers, B., Wink, S., Fredriksson, L., Di, Z., Hendriks, G., Vrieling, H., de Bont, H., & van de Water, B. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1536-3 · Cited by 65
Arafa, M. H., & Atteia, H. H. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00095-x · Cited by 65
Fan, X., Jiang, Y., Wang, Y., Tan, H., Zeng, H., Wang, Y., Chen, P., Qu, A., Gonzalez, F. J., Huang, M., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059535 · Cited by 63
Self-citationFan, X., Lv, H., Wang, L., Deng, X., & Ci, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01334 · Cited by 59
Li, H., Wu, N., Pu, C., Hsiao, C., Chang, D., & Hung, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-60050-1 · Cited by 59
Li, Y., Gao, M., Yin, L., Xu, L., Qi, Y., Sun, P., & Peng, J. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.035 · Cited by 59
Giridharan, V. V., Thandavarayan, R. A., Bhilwade, H. N., Ko, K. M., Watanabe, K., & Konishi, T. (2011) · Free Radical Research · doi:10.3109/10715762.2011.638291 · Cited by 58
Verma, A. K., Yadav, A., Dewangan, J., Singh, S. V., Mishra, M., Singh, P. K., & Rath, S. K. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.020 · Cited by 57
Ultramicronized palmitoylethanolamide (PEA-um ® ) in the treatment of idiopathic pulmonary fibrosis
Paola, R. D., Impellizzeri, D., Fusco, R., Cordaro, M., Siracusa, R., Crupi, R., Esposito, E., & Cuzzocrea, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.010 · Cited by 57
Farrerol Ameliorates APAP-induced Hepatotoxicity via Activation of Nrf2 and Autophagy
Wang, L., Wei, W., Xiao, Q., Yang, H., & Ci, X. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30677 · Cited by 57
Yehia, R., Saleh, S., El-Abhar, H. S., Saad, A. S., & Schaalan, M. F. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.015 · Cited by 56
Hou, Z., Chen, L., Fang, P., Cai, H., Tang, H., Peng, Y., Deng, Y., Cao, L.-J., Huan-de, L., Zhang, B., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00226 · Cited by 55
Self-citationSanjay, S., Girish, C., Toi, P. C., & Bobby, Z. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa048 · Cited by 55
Jiang, Z., Chu, H., Xi, M., Yang, T., Jia, J.-M., Huang, J., Guo, X., Zhang, X., You, Q., & Sun, H.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075076 · Cited by 52
The Role of Cyclo(His-Pro) in Neurodegeneration
Grottelli, S., Ferrari, I., Pietrini, G., Peirce, M. J., Minelli, A., & Bellezza, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081332 · Cited by 52
Ali, F. E. M., Sayed, A. M. M., El‐Bahrawy, A. H., Omar, Z. M. M., & Hassanein, E. H. M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119349 · Cited by 51
Khaleel, S. A., Raslan, N. A., Alzokaky, A. A., Ewees, M. G., Ashour, A. A., Abdel‐Hamied, H. E., & Abd‐Allah, A. R. A. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.002 · Cited by 49
Ibrahim, S. R. M., El‐Agamy, D. S., Abdallah, H. M., Ahmed, N., Elkablawy, M. A., & Mohamed, G. A. (2018) · Food & Function · doi:10.1039/c8fo00378e · Cited by 47
Zhou, Q., Wang, X., Shao, X., Wang, H., Liu, X., Ke, X., Xiong, C., Wei, L., & Zou, H. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4657651 · Cited by 47
Tuğcu, V., Özbek, E., Taşçı, A. İ., Kemahlı, E., Somay, A., Baş, M., Karaca, Ç., Altuğ, T., Çekmen, M., & Ozdogan, H. K. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06321.x · Cited by 46
Acarín, L., González, B., & Castellano, B. (2001) · Stroke · doi:10.1161/hs1001.097243 · Cited by 46
Chen, W., Li, S., Li, J., Zhou, W., Wu, S., Xu, S., Cui, K., Zhang, D. D., & Liu, B. (2016) · The FASEB Journal · doi:10.1096/fj.201500109r · Cited by 45
Kim, H. R., Kim, J. C., Kang, S. Y., Kim, H. O., Park, C. W., & Chung, B. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083968 · Cited by 45
Mahmoud, Y. I. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.079 · Cited by 43
Ogawa, T., Ishitsuka, Y., Inoue, S., Nakamura, Y., Saito, A., Okiyama, N., Fujisawa, Y., Furuta, J., Watanabe, R., & Fujimoto, M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.10.022 · Cited by 43
Yuan, Z., Yuan, Z., Hasnat, M., Zhang, H., Liang, P., Sun, L., Jiang, Z., & Zhang, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.009 · Cited by 43
Lv, Z., Shen, J., Gao, X., Ruan, Y., Ling, J., Sun, R., Dai, J., Fan, H., Cheng, X., & Cao, P. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00488-1 · Cited by 43
Verma, A. K., Yadav, A., Singh, S. V., Mishra, P., & Rath, S. K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.037 · Cited by 42
Ahmad, A., Alkharfy, K. M., Jan, B. L., Ahad, A., Ansari, M. A., Al-Jenoobi, F. I., & Raish, M. (2020) · Experimental Lung Research · doi:10.1080/01902148.2020.1726529 · Cited by 42
Lee, J., Song, K., Hiebert, P., Werner, S., Kim, T., & Kim, Y. S. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.12.008 · Cited by 41
Sun, H., Leng, B., Wu, Z., & Bian, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207805 · Cited by 40
Wang, J., Luo, W., Li, B., Lv, J., Ke, X., Ge, D., Dong, R., Wang, C., Han, Y., Zhang, C., et al. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.002 · Cited by 39
Choi, J. H., Jin, S. W., Lee, G. H., Han, E. H., Hwang, Y. P., & Jeong, H. G. (2021) · Antioxidants · doi:10.3390/antiox10010086 · Cited by 36
Feng, Z., Zhou, C., Dong, S., Liu, Z.-P., Liu, T., Zhou, L., & Zhou, X. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.01.016 · Cited by 33
Arctiin Antagonizes Triptolide‐Induced Hepatotoxicity via Activation of Nrf2 Pathway
Zhou, Y., Li, X., Yao, W., Han, J. H., & Wang, G. (2020) · BioMed Research International · doi:10.1155/2020/2508952 · Cited by 33
Sanjay, S., Girish, C., Toi, P. C., & Bobby, Z. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0008 · Cited by 32
Qin, X., Meghana, K., Sowjanya, N. L., Sushma, K. R., Krishna, C. G., Manasa, J., Sita, G. J. A., Gowthami, M., Honeyshmitha, D., Srikanth, G., et al. (2019) · BioFactors · doi:10.1002/biof.1502 · Cited by 31
Chen, Y.-Y., Chiang, S., Wu, H.-C., Kao, S.-T., Hsiang, C., Ho, T., & Lin, J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.197 · Cited by 30
Bai, Y., Lu, H., Hu, L., Hong, D., Ding, L., & Chen, B. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13216fp · Cited by 29
Sarıtemur, M., Ün, H., Çadırcı, E., Karakuş, E., Akpınar, E., Halıcı, Z., Uğan, R. A., Karaman, A., & Atmaca, H. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.01.002 · Cited by 28
Bleomycin-induced pulmonary toxicopathological changes in rats and its prevention by walnut extract
Beigh, S., Rashid, H., Sharma, S., Parvez, S., & Raisuddin, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.124 · Cited by 26
Liu, F.-C., Yu, H., Chou, A., Lee, H.-C., & Liao, C.-C. (2020) · PubMed Central · Cited by 24
de Freitas, M. S., Spohr, T. C. L. S., Benedito, A. B., Caetano, M. S., Margulis, B. A., Lopes, U. G., & Moura‐Neto, V. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03682-x · Cited by 23
Shaikh, S. B., & Bhandary, Y. P. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106676 · Cited by 23
Wang, C., Hu, N., Yu, L.-Y., Gong, L., Dai, X., Peng, C. Y., & Li, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110138 · Cited by 22
Kang, H. H., Kim, I. K., Yeo, C. D., Kim, S. W., Lee, H., Im, J., Kwon, H. Y., & Lee, S. H. (2020) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2020.0112 · Cited by 22
Yen, H., Chang, H., Majima, H. J., Chen, F.-Y., & Li, S.-H. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.022 · Cited by 21
Zhang, X., Wang, T., Yang, Y., Li, R., Ya, C., Li, R., Jiang, X., & Wang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110547 · Cited by 21
Self-citationRole of MicroRNA-155 in Triptolide-induced hepatotoxicity via the Nrf2-Dependent pathway
Li, Y., Guo, L., Hou, Z., Gong, H., Yan, M., & Zhang, B. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114489 · Cited by 21
Self-citationCampo, C., Filho, M. I. D. S., Weinhold, N., Goldschmidt, H., Hemminki, K., Merz, M., & Försti, A. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2007-9 · Cited by 20
He, X., Song, Y., Wang, L., & Xu, J. M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10817 · Cited by 20
Zhao, F., Feng, L., Liu, Q., Wang, H., Tang, C., Cheng, W., Deng, Y.-H., Wu, X., Yan, P., Duan, X., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1898213 · Cited by 20
Cited by
Balogun, O., Shao, D., Carson, M., King, T., Kosar, K., Zhang, R., Zeng, G., Cornuet, P., Goel, C., Lee, E., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000485 · Cited by 6
Metadata
- Authors
- Gao, W., Guo, L., Yang, Y., Wang, Y., Xia, S., Gong, H., Zhang, B.-K., & Yan, M.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2022-02-02
- Volume
- 9
- Pages
- 809952-809952
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W4210379313
- Cited by
- 320
- References
- 208
- FWCI
- 14.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.